TrademarkDir
GLOBAL COUNCIL ON ALZHEIMER'S DISEASE
LIVE

Serial Number

86362061

Owner

Otsuka America Pharmaceutical, Inc.

Attorney

B. Brett Heavner

First Use Date

Oct 31, 2014

Filing Date

Aug 9, 2014

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GLOBAL COUNCIL ON ALZHEIMER'S DISEASE Trademark

Serial Number: 86362061 • Registration: 4929260

GLOBAL COUNCIL ON ALZHEIMER'S DISEASE is a trademark filed by Otsuka America Pharmaceutical, Inc. on August 9, 2014. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Otsuka America Pharmaceutical, Inc.

2440 Research Boulevard
Rockville, MD 20850

Entity Type: 03

Trademark Details

Filing Date

August 9, 2014

Registration Date

March 29, 2016

First Use Anywhere

October 31, 2014

First Use in Commerce

October 31, 2014

Goods & Services

Educational services, namely, conducting educational programs and providing courses in the field of Alzheimer's disease care and treatment; on-line publishing of electronic publications [ ; on-line journals, namely, blogs in the fields of Alzheimer's disease care and treatment ]

Printed materials, namely, brochures, pamphlets, wallboards, posters in the field of Alzheimer's disease care and treatment

[ Research and development in the field of Alzheimer's disease care and treatment ]

Promoting awareness of Alzheimer's disease care and treatment

Filing History

POST REGISTRATION ACTION MAILED - SEC. 8 & 9
May 6, 2026 PR89
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 4, 2026 APRE
TEAS SECTION 8 & 9 RECEIVED
Mar 2, 2026 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Mar 29, 2025 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Aug 12, 2022 NAS8
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Aug 12, 2022 8.PR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 12, 2022 APRE
TEAS SECTION 8 RECEIVED
Mar 15, 2022 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 29, 2021 REM1
CORRECTION UNDER SECTION 7 - PROCESSED
May 29, 2017 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 22, 2017 APRE
TEAS SECTION 7 REQUEST RECEIVED
Feb 7, 2017 ES7R
REGISTERED-SUPPLEMENTAL REGISTER
Mar 29, 2016 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 22, 2016 PREV
ASSIGNED TO LIE
Feb 20, 2016 ALIE
EXPARTE APPEAL TERMINATED
Jan 22, 2016 EXPT
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jan 21, 2016 CNTA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Jan 21, 2016 AAUA
USE AMENDMENT ACCEPTED
Jan 20, 2016 IUAA
EX PARTE APPEAL-INSTITUTED
Dec 28, 2015 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Dec 28, 2015 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Dec 28, 2015 EXAF
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 22, 2015 ERFR
AMENDMENT TO USE PROCESSING COMPLETE
Dec 22, 2015 AUPC
USE AMENDMENT FILED
Dec 22, 2015 IUAF
TEAS AMENDMENT OF USE RECEIVED
Dec 21, 2015 EAAU
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 25, 2015 GNFN
FINAL REFUSAL E-MAILED
Jun 25, 2015 GNFR
FINAL REFUSAL WRITTEN
Jun 25, 2015 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 30, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 29, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 29, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 1, 2014 GNRN
NON-FINAL ACTION E-MAILED
Dec 1, 2014 GNRT
NON-FINAL ACTION WRITTEN
Dec 1, 2014 CNRT
ASSIGNED TO EXAMINER
Nov 24, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 19, 2014 NWOS
NEW APPLICATION ENTERED
Aug 13, 2014 NWAP

Related Trademarks

More from this Owner

POWER AHEAD ADHD HEALTH, EDUCATION & ADVOCACY DIALOGUE logo

POWER AHEAD ADHD HEALTH, EDUCATION & ADVOCACY DIALOGUE

POWER AHEAD ADHD HEALTH, EDUCATION & ADVOCACY DIALOGUE logo

POWER AHEAD ADHD HEALTH, EDUCATION & ADVOCACY DIALOGUE

POWER AHEAD ADHD HEALTH, EDUCATON & ADVOCACY DIALOGUE logo

POWER AHEAD ADHD HEALTH, EDUCATON & ADVOCACY DIALOGUE

POWER AHEAD ADHD HEALTH, EDUCATON & ADVOCACY DIALOGUE logo

POWER AHEAD ADHD HEALTH, EDUCATON & ADVOCACY DIALOGUE

IDENTIC PHARMACEUTICAL

IDENTIC PHARMACEUTICAL

IDENTIC PHARMACEUTICAL

IDENTIC PHARMACEUTICAL